Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of WIBP DTacP vaccine in healthy infants
ChiCTR2200064991Phase 3Not yet recruiting
- Sponsor
- Henan Provincial Center for Disease Control and Prevention
- Start
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of diphtheria + tetanus + acellular pertussis vaccine and diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine in pertussis, diphtheria and Tetanus (6 arms), sponsored by Henan Provincial Center for Disease Control and Prevention. Primary endpoints: Incidence of adverse events, Incidence of serious adverse events and 2 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccinediphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on ChiCTR2200064991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064991.